mouse anti rat wilms tumor 1 wt 1 Search Results


94
Thermo Fisher gene exp wt1 mm01337048 m1
Gene Exp Wt1 Mm01337048 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp wt1 mm01337048 m1/product/Thermo Fisher
Average 94 stars, based on 1 article reviews
gene exp wt1 mm01337048 m1 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
Novus Biologicals anti wilms tumor 1
Anti Wilms Tumor 1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti wilms tumor 1/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
anti wilms tumor 1 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

95
Proteintech wt1
Wt1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wt1/product/Proteintech
Average 95 stars, based on 1 article reviews
wt1 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
Boster Bio wilms tumor 1 wt1
Antibodies used in this study.
Wilms Tumor 1 Wt1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wilms tumor 1 wt1/product/Boster Bio
Average 90 stars, based on 1 article reviews
wilms tumor 1 wt1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology tumor 1 wt1
Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing <t>WT1</t> + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.
Tumor 1 Wt1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tumor 1 wt1/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
tumor 1 wt1 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
Agilent technologies monoclonal mouse anti-human wilms' tumor 1 (wt1; 6f-h2) protein
Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing <t>WT1</t> + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.
Monoclonal Mouse Anti Human Wilms' Tumor 1 (Wt1; 6f H2) Protein, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal mouse anti-human wilms' tumor 1 (wt1; 6f-h2) protein/product/Agilent technologies
Average 90 stars, based on 1 article reviews
monoclonal mouse anti-human wilms' tumor 1 (wt1; 6f-h2) protein - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Agilent technologies mouse monoclonal anti-wt1 (wilms tumor 1
Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing <t>WT1</t> + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.
Mouse Monoclonal Anti Wt1 (Wilms Tumor 1, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti-wt1 (wilms tumor 1/product/Agilent technologies
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-wt1 (wilms tumor 1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

98
Thermo Fisher gene exp wt1 hs01103751 m1
Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing <t>WT1</t> + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.
Gene Exp Wt1 Hs01103751 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp wt1 hs01103751 m1/product/Thermo Fisher
Average 98 stars, based on 1 article reviews
gene exp wt1 hs01103751 m1 - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

90
Agilent technologies monoclonal anti-human wilms tumor 1 (wt1) mouse antibody
Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing <t>WT1</t> + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.
Monoclonal Anti Human Wilms Tumor 1 (Wt1) Mouse Antibody, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal anti-human wilms tumor 1 (wt1) mouse antibody/product/Agilent technologies
Average 90 stars, based on 1 article reviews
monoclonal anti-human wilms tumor 1 (wt1) mouse antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc tumor 1
Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing <t>WT1</t> + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.
Tumor 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tumor 1/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
tumor 1 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Thermo Fisher wilms tumor-1 antigen (wt1) #6fh2
Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing <t>WT1</t> + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.
Wilms Tumor 1 Antigen (Wt1) #6fh2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wilms tumor-1 antigen (wt1) #6fh2/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
wilms tumor-1 antigen (wt1) #6fh2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

88
Thermo Fisher gene exp pax2 hs01057416 m1
Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing <t>WT1</t> + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.
Gene Exp Pax2 Hs01057416 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp pax2 hs01057416 m1/product/Thermo Fisher
Average 88 stars, based on 1 article reviews
gene exp pax2 hs01057416 m1 - by Bioz Stars, 2026-03
88/100 stars
  Buy from Supplier

Image Search Results


Antibodies used in this study.

Journal: Molecular Metabolism

Article Title: P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response

doi: 10.1016/j.molmet.2020.101089

Figure Lengend Snippet: Antibodies used in this study.

Article Snippet: Wilms Tumor-1 (WT1) , Boster Biological Technology , #M00199-1 , Rabbit , 1 μg/ml (IHC).

Techniques:

P2Y2R deficiency protects against podocyte loss and glomerular injury in DN. (A) Relative mRNA levels of Nphs1 (nephrin) and Nphs2 (podocin) were determined by real-time PCR analysis (n = 3–5). (B) Localisation of WT1, a podocyte marker, was analysed by immunohistochemistry, and representative images are shown. The number of stained podocytes per glomeruli was counted by using ImageJ software (n = 3). (C) Kidney sections were stained with PAS staining and glomerular morphological changes were scored as described in the method section (n = 3). Data are presented as mean ± SEM. One-way ANOVA was used for statistical analysis followed by Bonferroni's multiple comparisons test. ∗∗∗p < 0.001 vs WT control mice; and ### p < 0.001 vs WT DN mice. Scale bar, 50 μm.

Journal: Molecular Metabolism

Article Title: P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response

doi: 10.1016/j.molmet.2020.101089

Figure Lengend Snippet: P2Y2R deficiency protects against podocyte loss and glomerular injury in DN. (A) Relative mRNA levels of Nphs1 (nephrin) and Nphs2 (podocin) were determined by real-time PCR analysis (n = 3–5). (B) Localisation of WT1, a podocyte marker, was analysed by immunohistochemistry, and representative images are shown. The number of stained podocytes per glomeruli was counted by using ImageJ software (n = 3). (C) Kidney sections were stained with PAS staining and glomerular morphological changes were scored as described in the method section (n = 3). Data are presented as mean ± SEM. One-way ANOVA was used for statistical analysis followed by Bonferroni's multiple comparisons test. ∗∗∗p < 0.001 vs WT control mice; and ### p < 0.001 vs WT DN mice. Scale bar, 50 μm.

Article Snippet: Wilms Tumor-1 (WT1) , Boster Biological Technology , #M00199-1 , Rabbit , 1 μg/ml (IHC).

Techniques: Real-time Polymerase Chain Reaction, Marker, Immunohistochemistry, Staining, Software, Control

Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing WT1 + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.

Journal: Physiological Reports

Article Title: Renal stromal miRNAs are required for normal nephrogenesis and glomerular mesangial survival

doi: 10.14814/phy2.12537

Figure Lengend Snippet: Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing WT1 + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.

Article Snippet: Primary antibodies were used at 1:100 dilution and include: Six2 (Proteintech #11562-1-AP, Chicago, IL), Forkhead box D1 (FoxD1) (Santa Cruz #sc-47585, Dallas, TX), Calbindin (Sigma #C9848, St. Louis, MO), annexin A2 (Anxa2) (Cell Signaling #8235, Danvers, MA), Neural cell adhesion molecule (Ncam) (Sigma #C9672), Tenascin C (Millipore #AB19011, Billerica, MA), Yes-associated protein 1 (Yap) (Cell Signaling #4912), phospho-Yap (pYap) (Cell Signaling #4911), Desmin (Dako #M076029-2, Carpinteria, CA), Wilm’s tumor-1 (WT1) (Santa Cruz #sc-192), Platelet-derived growth factor receptor- β (Pdgfr β ) (eBiosciences, Millipore #14-1402), α -smooth muscle actin (SMA)-FITC (Sigma #F3777), Renin (Santa Cruz #sc-27318), Lef1 (Cell Signaling #2230), Pecam (BD Pharmingen #BDB550274, San Jose, CA), Bcl2-like 11 (Bim) (Cell Signaling #2819), Meis1/2/3 (Millipore #05-779), aCaspase3 (Promega #PRG7481, Madison, WI), and phospho-histone H3 (Sigma #H9161).

Techniques: Immunofluorescence, Staining, Migration, Control, Expressing